BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/28/2020 3:42:19 AM | Browse: 925 | Download: 1225
 |
Received |
|
2019-09-20 17:36 |
|
Peer-Review Started |
|
2019-09-20 17:36 |
|
To Make the First Decision |
|
2019-12-19 00:18 |
|
Return for Revision |
|
2019-12-19 02:49 |
|
Revised |
|
2020-02-03 16:41 |
|
Second Decision |
|
2020-02-14 10:13 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-02-14 22:37 |
|
Articles in Press |
|
2020-02-14 22:37 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-02-26 08:02 |
|
Publish the Manuscript Online |
|
2020-02-28 03:42 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Therapies to modulate gut microbiota: Past, present and future
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Akshita Gupta, Srishti Saha and Sahil Khanna |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sahil Khanna, MBBS, MSc, Assistant Professor, Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, United States. khanna.sahil@mayo.edu |
| Key Words |
Fecal microbiota transplantation; Microbial replacement therapies; Clostridioides difficile infection; Microbiome; Microbiota; Inflammatory bowel disease |
| Core Tip |
The human gut microbiota comprises of a diverse array of microorganisms responsible for the maintenance of health. Disruption of this microbial milieu has been implicated in various disorders. These include, but are not limited to, diseases such as Clostridioides difficile infection and inflammatory bowel disease. Microbial replacement therapy or fecal microbiota transplantation is highly effective for treating recurrent Clostridioides difficile infection. Its role in other gastrointestinal and non-gastrointestinal disorders is under investigation. This review summarizes the current indications and evidence for the use of such therapies, and briefly touches upon potential therapeutic applications in the future. |
| Publish Date |
2020-02-28 03:42 |
| Citation |
Gupta A, Saha S, Khanna S. Therapies to modulate gut microbiota: Past, present and future. World J Gastroenterol 2020; 26(8): 777-788 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i8/777.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i8.777 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
